
The Brattle Group announced that David L. Sunding has been elected as Brattle’s next President, effective July 1, 2020. Dr. Sunding succeeds M. Alexis Maniatis, who served as Brattle’s President for more than a decade and will return to full-time consulting at the firm.
“The firm has flourished under Alexis’s guidance. We’re thankful for his years of vision and leadership, which have helped us to maintain our unique firm culture while tripling our number of employees and expanding our office locations in North America, Europe, and Asia-Pacific,” said Michael Cragg, Chairman of Brattle’s Board of Directors.
“Dave embodies the firm’s core values of collaboration, respect, integrity, and performance,” shared Mr. Maniatis. “His leadership experience in consulting and academics is a great asset, and we’re energized as we think ahead to the firm’s long-term future.”
Dr. Sunding has been a Principal in the San Francisco office for nearly 10 years and a member of Brattle’s Board of Directors since 2019. While he has gained experience at several international economic consultancies, including one that he co-founded, he feels that Brattle is unique because of its focus on exceptional client services and career development. His practice focuses, and he regularly serves as a testifying expert, on environmental and competition economics.
Full Content: The Brattle Group
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Orders Apple to Address Fortnite App Block or Face Court Hearing
May 19, 2025 by
CPI
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas